| 1 |
18164863 | Use of local (111)in-capromab pendetide scan results to predict outcome after salvage radiotherapy for prostate cancer. | 2008 Jun 1 |
1 |
| 2 |
17293236 | Long-term follow-up of 111In-capromab pendetide (ProstaScint) scan as pretreatment assessment in patients who undergo salvage radiotherapy for rising prostate-specific antigen after radical prostatectomy for prostate cancer. | 2007 Mar 1 |
2 |
| 3 |
11920467 | Clinical utility of indium 111-capromab pendetide immunoscintigraphy in the detection of early, recurrent prostate carcinoma after radical prostatectomy. | 2002 Feb 15 |
2 |
| 4 |
12497003 | Evaluation of preoperative ProstaScint scans in the prediction of nodal disease. | 2002 |
2 |
| 5 |
10869655 | Indium-111 capromab pendetide (ProstaScint) uptake in neurofibromatosis. | 2000 Jul 1 |
2 |
| 6 |
9598514 | 111Indium-capromab pendetide in the evaluation of patients with residual or recurrent prostate cancer after radical prostatectomy. The ProstaScint Study Group. | 1998 Jun |
1 |